SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-033349
Filing Date
2019-06-03
Accepted
2019-06-03 10:41:18
Documents
1
Period of Report
2019-05-30

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3599
  Complete submission text file 0001104659-19-033349.txt   4973
Mailing Address C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
Rosen Howard B (Reporting) CIK: 0001307068 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 19872480

Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations